FDA Drug Application (202344) for BINOSTO by MISSION PHARMA

Back to FDA Applications sponsored by MISSION PHARMA

Application Number202344
Product Number001
FormTABLET, EFFERVESCENT;ORAL
DosageEQ 70MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBINOSTO
Active IngredientALENDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient ALENDRONATE SODIUM4


Back to FDA Applications sponsored by MISSION PHARMA